RIPK3 and pancreatic adenocarcinoma: Conversely, in the cases of RIPK3 and FASLG, between the CNV mutation rates and the expression levels, showed a negative correlation in THYM and pancreatic adenocarcinoma (PAAD) (Fig. S2F).